Zoetis (ZTS) Equity Average (2012 - 2026)
Zoetis (ZTS) reported Equity Average of $3.3 billion for Q1 2026, down 31.53% year-over-year from $4.9 billion in Q1 2025, and down 24.57% quarter-over-quarter from $4.4 billion in Q4 2025.
Zoetis (ZTS) Equity Average (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Equity Average data on file, last reported at $3.3 billion in Q1 2026.
- Equity Average for Q1 2026 came in at $3.3 billion, down 31.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 billion (down 31.53% YoY), and the FY2025 annual result was $4.1 billion, down 16.02% from the prior year.
- Equity Average eased to $3.3 billion in Q1 2026 per ZTS's latest filing, from $4.4 billion in the prior quarter.
- Over five years, Equity Average peaked at $5.2 billion in Q3 2025 and troughed at $3.3 billion in Q1 2026.
- A 5-year average of $4.7 billion and a median of $4.8 billion in 2023 frame the typical range for Equity Average.
- The sharpest annual moves came in 2022 and 2026: Equity Average rose 17.0% in 2022, then tumbled 31.53% in 2026.
- A 5-year view of Equity Average shows it stood at $4.5 billion in 2022, then grew by 11.03% to $5.0 billion in 2023, then climbed by 0.13% to $5.0 billion in 2024, then dropped by 12.55% to $4.4 billion in 2025, then retreated by 24.57% to $3.3 billion in 2026.
- Business Quant data shows ZTS's Equity Average at $3.3 billion in Q1 2026, $4.4 billion in Q4 2025, and $5.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.15 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 493.55 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 76.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.32 Bn |
| Dec 31, 2025 | 4.41 Bn |
| Sep 30, 2025 | 5.19 Bn |
| Jun 30, 2025 | 4.92 Bn |
| Mar 31, 2025 | 4.85 Bn |
| Dec 31, 2024 | 5.04 Bn |
| Sep 30, 2024 | 5.10 Bn |
| Jun 30, 2024 | 5.01 Bn |
| Mar 31, 2024 | 5.02 Bn |
| Dec 31, 2023 | 5.03 Bn |
| Sep 30, 2023 | 4.85 Bn |
| Jun 30, 2023 | 4.56 Bn |
| Mar 31, 2023 | 4.45 Bn |
| Dec 31, 2022 | 4.53 Bn |
| Sep 30, 2022 | 4.62 Bn |
| Jun 30, 2022 | 4.62 Bn |
| Mar 31, 2022 | 4.60 Bn |
| Dec 31, 2021 | 4.61 Bn |
| Sep 30, 2021 | 4.52 Bn |
| Jun 30, 2021 | 4.22 Bn |